rood blauwe elepsis logo Belegger.nl
Uitgebreid zoeken

BioPharma Terug naar discussie overzicht

PRW - Pro-Pharmaceuticals Inc.

619 Posts
Pagina: «« 1 2 3 4 5 6 ... 31 »» | Laatste | Omlaag ↓
  1. welshterrier 5 14 februari 2007 17:02

    • welshterrier 5

      Lid sinds: 23 mrt 2004

      Laatste bezoek: 26 mrt 2025

    • Aanbevelingen

      Ontvangen: 291

      Gegeven: 1101

    •    Aantal posts: 20.113

    nu alweer 93, ik heb Binck realtime
    je hebt gelijk ik haal hem uit de verkoop, ik heb ook het gevoel dat men ze heel graag wil hebben.
    Komt tenslotte van heel hoog.

    p.s. ik blijf veranderen, stijgt als een speer. gelukkig net op tijd uit de verkoop
  2. [verwijderd] 14 februari 2007 17:11

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Hhahahah ja man wat een handel,k zit zelf bij Abn en heb helaas geen real-time.
    De koers gaat zich herstel en hard ook,maar kanker is ook volksziekte nummer 1 in de wereld.
    Er is grote behoefde aan deze nieuwe techniek om de ziekte te kunnen bestrijden.

    Greetz BB
  5. MyOpinion 14 februari 2007 17:25

    • MyOpinion

      Lid sinds: 22 jan 2005

      Laatste bezoek: 31 mrt 2025

    • Aanbevelingen

      Ontvangen: 243

      Gegeven: 185

    •    Aantal posts: 1.551

    finance.google.com/finance?cid=681566

    Pro-Pharm. seeks OK of DAVANAT with chemo
    NEWTON, Mass., Feb. 12 (UPI) -- Pro-Pharmaceuticals said Monday it will meet with U.S. regulators on getting approval to use DAVANAT with a top chemotherapy drug.

    The company said it would meet with officials from the Food and Drug Administration to discuss plans for submitting a new drug application for its drug DAVANAT to be co-administered with one of the most widely used chemotherapy agents, 5-Fluorouracil, to treat cancer patients.

    DAVANAT, the company's lead drug candidate, is a carbohydrate polymer, composed of mannose and galactose, Pro-Pharmaceuticals said, while 5-FU is a chemotherapy drug that is used to treat cancers such as colorectal, breast and gastrointestinal.

    "Our goal is to commercialize our compounds and get them to market in multiple applications and indications," said David Platt, president and chief executive officer of Pro-Pharmaceuticals. "To gain FDA marketing approval for our lead compound Davanat would be a major milestone in the development of our technology. Pharmaceutical companies are also evaluating our carbohydrate compounds for use with their chemotherapeutic agents."

    What is Pro-Pharmaceuticals' patent position?

    The United States Patent and Trademark Office has issued five patents to Pro-Pharmaceuticals. These patents and their corresponding international counterparts strengthen Pro-Pharmaceuticals' intellectual property related to the development of its proprietary carbohydrate-based therapeutic compounds.

    What is the business strategy of Pro-Pharmaceuticals?

    We see a market demand for target delivery of chemotherapy drugs that provide increased efficacy for treating cancer tumors while reducing the toxic side effects of chemotherapy. DAVANAT® is a non-toxic target delivery technology based on a proprietary carbohydrate compound that we are combining with chemotherapy drugs that have been approved by the FDA and are widely used.

    With respect to DAVANAT® in particular, our business objective is to develop it initially in combination with 5-FU and other chemotherapy drugs and biologics, and subsequently for other diseases, so that as a target delivery product it has broad application. Our clinical trial data to date in late stage patients shows that DAVANAT® keeps 5-FU in the blood stream substantially longer than 5-FU without DAVANAT® with no increase in key toxicity indicators. We are currently conducting clinical trials with first line colorectal and biliary cancer patients to demonstrate increased efficacy of DAVANAT®. Additionally we believe DAVANAT® may reduce the toxicity, increase the solubility and increase the half-life in the blood stream of other chemotherapeutic drugs thereby enhancing their usefulness. We plan to collaborate with pharmaceutical companies interested in improving compounds in these areas.

    When will the company complete a collaboration, licensing or marketing agreement with large pharma?

    We plan to continue to actively discuss potential collaborations with large pharmaceutical companies who are evaluating our technology. Our goal is to facilitate collaborations that will enable us to get our compounds to market quickly and in multiple applications.





  19. MyOpinion 14 februari 2007 18:44

    • MyOpinion

      Lid sinds: 22 jan 2005

      Laatste bezoek: 31 mrt 2025

    • Aanbevelingen

      Ontvangen: 243

      Gegeven: 185

    •    Aantal posts: 1.551

    Davanat zit op dit moment in een fase lll clinical trial en het bedrijf gaat op korte termijn een FDA approval aanvragen.
  20. welshterrier 5 14 februari 2007 18:48

    • welshterrier 5

      Lid sinds: 23 mrt 2004

      Laatste bezoek: 26 mrt 2025

    • Aanbevelingen

      Ontvangen: 291

      Gegeven: 1101

    •    Aantal posts: 20.113

    ff winst genomen op 1,04, probeer weer lager in te stappen. gister day high 90 en slot op 72
    misschien vandaag weer op het eind winstnemers...
    probeer rond de 90-92 ct weer in te stappen maar dit is in de knip, toch leuk op een natte woensdagmiddag.:-)))
619 Posts
Pagina: «« 1 2 3 4 5 6 ... 31 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.124
AB InBev 2 5.538
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.213
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.865
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.846
Aedifica 3 926
Aegon 3.258 323.086
AFC Ajax 538 7.092
Affimed NV 2 6.305
ageas 5.844 109.906
Agfa-Gevaert 14 2.063
Ahold 3.538 74.353
Air France - KLM 1.025 35.295
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.051
Alfen 16 25.301
Allfunds Group 4 1.517
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 423
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.953
AMG 971 134.443
AMS 3 73
Amsterdam Commodities 305 6.745
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 496
Antonov 22.632 153.605
Aperam 92 15.063
Apollo Alternative Assets 1 17
Apple 5 386
Arcadis 252 8.807
Arcelor Mittal 2.034 320.999
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.355
Aroundtown SA 1 221
Arrowhead Research 5 9.751
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.623
ASML 1.766 110.305
ASR Nederland 21 4.513
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.958
Axsome Therapeutics 1 177
Azelis Group 1 67
Azerion 7 3.449